MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14712598.2020.1694900

Медицинская библиотека · Expert opinion on biological therapy · 2019

Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry.

Tužil Jan, Mlčoch Tomáš, Jirčíková Jitka, Závada Jakub, Nekvindová Lucie, Svoboda Michal, Uher Michal, Křístková Zlatuše, Vencovský Jiří, Pavelka Karel, Doležal Tomáš

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Objectives

To assess the role of short-term response to first anti-TNF in long-term prediction of disability.

Methods

In nationwide registry ATTRA, we identified ankylosing spondylitis patients starting anti-TNF between 01/2003 and 12/2016. Full disability and work impairment (WI; WPAI questionnaire) were predicted via the Cox- and lagged-parameter mixed-effect regression.

Results

2,274 biologicals-naïve patients newly indicated to anti-TNF were prospectively followed (6,333 patient-years; median follow-up 1.9 years). Reaching BASDAI < 4 (77.4%) and ASDAS-CRP < 2.1 (61.1%) after 3 months of anti-TNF both decreased the risk of future disability by ≈2.5-fold. ASDAS-CRP < 2.1 predicted non-disability better than BASDAI < 4 & CRP < 5 mg/L (p = 0.032). BASDAI < 4 & CRP < 5 mg/L was comparable to BASDAI < 4 (p = 0.941) and to BASDAI change by >50% or by >2 points (p = 0.902). ASDAS-CRP change >1.1 and >2.0 both failed to predict non-disability. Once on anti-TNF therapy, the strongest predictor of WI was Pain (SF36). Yearly increase in indirect costs remains below €3,000 in those reaching ASDAS-CRP < 2.1.

Conclusions

Low disease activity measured by ASDAS-CRP ≤ 2.1 should be used to measure the outcome of new anti-TNF therapy. Continuous WI could be decreased through pain management.

Для цитирования: Tužil Jan, Mlčoch Tomáš, Jirčíková Jitka, Závada Jakub, Nekvindová Lucie, Svoboda Michal, Uher Michal, Křístková Zlatuše, Vencovský Jiří, Pavelka Karel, Doležal Tomáš. Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry.. Expert opinion on biological therapy. 2019. DOI: 10.1080/14712598.2020.1694900.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.